ArticleAntibiotics (Basel, Switzerland)2022
New Insights into
Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Association Between Biofilm Phenotype and Antimicrobial Resistance in FoodborneAntibiotics (Basel, Switzerland) · 2026Article
- Investigation ofFoods (Basel, Switzerland) · 2025Article
- Investigating the Biological Characteristics and Pathogenic Potential ofMicroorganisms · 2025Article
- Exploring the dynamic relationship between antimicrobial resistance, virulence fitness, and host responses in Listeria monocytogenes infections.Scientific reports · 2025Article
- A cross-sectional molecular epidemiological study of biofilm-producing methicillin-resistant Staphylococcus aureus.Medicine · 2025Observational
- Review
- Novel integrated approach modeling proanthocyanidins and bacteriophages to combat multidrugFrontiers in veterinary science · 2025Article
- Advanced therapeutic strategy for managing surgical site infections with natural nanoemulsion-antimicrobial combination.Frontiers in pharmacology · 2025Article
- Pulmonary and extra-pulmonary infections caused by classical and hypervirulentFrontiers in microbiology · 2025Article
- Eco-friendly silver nanoparticles from garlic: a novel therapeutic approach for treatingFrontiers in cellular and infection microbiology · 2025Article
- Development of an internalin-based double-antibody sandwich quantitative ELISA for the detection ofFrontiers in veterinary science · 2025Article
- Correlation between Antibiotics-Resistance, Virulence Genes and Genotypes among Klebsiella pneumoniae Clinical Strains Isolated in Guangzhou, China.Current microbiology · 2024Article
- Prevalence, antibiogram and molecular characterization of Listeria monocytogenes from ruminants and humans in New Valley and Beheira Governorates, Egypt.BMC veterinary research · 2024Article
- Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2024Article
- A Mini-Review of Anti-Listerial Compounds from Marine Actinobacteria (1990-2023).Antibiotics (Basel, Switzerland) · 2024Review
- Proven anti-virulence therapies in combating methicillin- and vancomycin-resistantFrontiers in cellular and infection microbiology · 2024Article
- Irradiation as a Promising Technology to Improve Bacteriological and Physicochemical Quality of Fish.Microorganisms · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Listeriosis is one of the most common foodborne diseases caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.